Wiley expands its KnowItAll solutions with new tools for LC-MS analysis, enterprise data management, and additional spectral advances

The latest KnowItAll software accelerates spectral analysis, featuring automated LC-MS tools and extensive spectral libraries to optimize research workflows.

FDA approves subcutaneous Ocrevus, broadening access to Roche and Genentech blockbuster

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 14, 2024

Study unlock secrets of Zika virus’s multipurpose enzyme and reveals therapeutic vulnerability

Viruses have limited genetic material-;and few proteins-;so all the pieces must work extra hard. Zika is a great example; the virus only produces 10 proteins.

December 9, 2023

After first-line approval in DLBCL, debate continues around benefit from Roche’s ADC Polivy

The FDA approved Roche and Genentech’s antibody-drug conjugate Polivy in April as a first-line treatment for diffuse large B-cell lymphoma (DLBCL) alongside a chemotherapy regimen

August 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.